Christopher Glynn joined Kenyon & Kenyon in 1998 as a full time scientific advisor and legal intern while he attended law school at Fordham University. Since 2003, he has continued at the firm as an associate with a practice that includes patent litigation, patent prosecution, client counseling and opinion work.
Dr. Glynn has many years of experience preparing and prosecuting patent applications; preparing validity, infringement and freedom-to-operate opinions; and handling due diligence reviews in the context IP sales and acquisitions. This work has been in the areas of chemistry and organic synthesis, polymer chemistry, pharmaceuticals including small molecules and drug delivery systems, material science and biotechnology. Dr. Glynn has been extensively involved in the support of foreign counsel with foreign patent prosecution and with invalidity and opposition proceedings, particularly in the Europe, South Korea and Japan.
Dr. Glynn has experience in patent litigations involving pharmaceutical products, dietary supplements, chemical processes and DNA diagnostics. He has significant experience with ANDA patent litigation under the Hatch-Waxman Act.
Dr. Glynn received his Ph.D. from Clark University in Organic and Inorganic Chemistry in 1998 for his work in the design and preparation of ferrimagnetic materials. His research involved the multi-step synthesis of novel organic ligands and organo-metallic coordination polymers.